Cargando…
Sustained Complete Response after Maintenance Therapy with Topotecan and Erlotinib for Recurrent Cervical Cancer with Distant Metastases
INTRODUCTION: Recurrent cervical cancer is associated with a poor prognosis. Most treatment responses are partial and of short duration. The development of new therapies is vital to improve treatment for recurrent disease. Epidermal growth factor receptor (EGFR) inhibitors may have a role in this se...
Autores principales: | Callegaro-Filho, Donato, Kavanagh, John J., Nick, Alpa M., Ramirez, Pedro T., Schmeler, Kathleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934679/ https://www.ncbi.nlm.nih.gov/pubmed/24575024 http://dx.doi.org/10.1159/000358916 |
Ejemplares similares
-
Spontaneous Healing of Corneal Perforation after Temporary Discontinuation of Erlotinib Treatment
por: Morishige, Naoyuki, et al.
Publicado: (2014) -
Sustained Response of a Clivus Chordoma to Erlotinib after Imatinib Failure
por: Houessinon, Aline, et al.
Publicado: (2015) -
Carcinoma of Unknown Primary Site Treated with Carboplatin + Paclitaxel + Bevacizumab + Erlotinib and Its Maintenance Chemotherapy
por: Yasui, Hirotoshi, et al.
Publicado: (2014) -
Endoscopic Surgery for Traumatic Acute Subdural Hematoma
por: Kon, Hiroyuki, et al.
Publicado: (2014) -
Unmasking Cryptococcal Meningitis Immune Reconstitution Inflammatory Syndrome due to Granulocyte Colony-Stimulating Factor Use in a Patient with a Poorly Differentiated Germ Cell Neoplasm
por: Bahr, Nathan C., et al.
Publicado: (2014)